Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Renovaro Inc (RENB)

Renovaro Inc (RENB)
0.3700 x 8 0.3878 x 40
Post-market by (Cboe BZX)
0.3482 -0.0535 (-13.32%) 04/22/25 [NASDAQ]
0.3700 x 8 0.3878 x 40
Post-market 0.3877 +0.0395 (+11.34%) 19:51 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.3412
Day High
0.4479
Open 0.4122
Previous Close 0.4017 0.4017
Volume 637,000 637,000
Avg Vol 787,435 787,435
Stochastic %K 19.34% 19.34%
Weighted Alpha -78.60 -78.60
5-Day Change -0.0103 (-2.87%) -0.0103 (-2.87%)
52-Week Range 0.3214 - 2.3400 0.3214 - 2.3400
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,757
  • Shares Outstanding, K 158,717
  • Annual Sales, $ 0 K
  • Annual Income, $ -80,650 K
  • EBIT $ -24 M
  • EBITDA $ 31 M
  • 60-Month Beta 0.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.68
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.58
  • Most Recent Earnings $-0.02 on 02/19/25
  • Next Earnings Date 05/21/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 289.03% ( +108.42%)
  • Historical Volatility 111.80%
  • IV Percentile 82%
  • IV Rank 27.17%
  • IV High 956.12% on 11/07/24
  • IV Low 40.11% on 09/13/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 457
  • Volume Avg (30-Day) 113
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 1,846
  • Open Int (30-Day) 3,126

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3214 +8.34%
on 04/10/25
Period Open: 0.7005
0.7338 -52.55%
on 03/25/25
-0.3523 (-50.29%)
since 03/21/25
3-Month
0.3214 +8.34%
on 04/10/25
Period Open: 0.7969
1.4000 -75.13%
on 02/26/25
-0.4487 (-56.31%)
since 01/22/25
52-Week
0.3214 +8.34%
on 04/10/25
Period Open: 2.1500
2.3400 -85.12%
on 06/10/24
-1.8018 (-83.80%)
since 04/22/24

Most Recent Stories

More News
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

RENB : 0.3482 (-13.32%)
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

RENB : 0.3482 (-13.32%)
Renovaro Provides Update to Definitive Agreement with Predictive Oncology

RENB : 0.3482 (-13.32%)
POAI : 0.8923 (+2.85%)
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

RENB : 0.3482 (-13.32%)
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

RENB : 0.3482 (-13.32%)
Renovaro Announces $15 million in Equity Committed

RENB : 0.3482 (-13.32%)
Renovaro: Fiscal Q2 Earnings Snapshot

Renovaro: Fiscal Q2 Earnings Snapshot

RENB : 0.3482 (-13.32%)
Investors Eye Biotech Sector as Cancer Therapy Market Surges

/CNW/ -- USA News Group News Commentary – Amid the excitement surrounding Project Stargate—the $500 billion investment aimed at revolutionizing AI-driven data...

ONCY : 0.6000 (+4.35%)
RENB : 0.3482 (-13.32%)
POAI : 0.8923 (+2.85%)
DGX : 172.84 (+6.78%)
GRAL : 29.69 (+12.38%)
ONC.TO : 0.84 (+6.33%)
Renovaro Issues Shareholder Letter and Provides Corporate Update

RENB : 0.3482 (-13.32%)
Renovaro Appoints Nathen Fuentes as Chief Financial Officer

RENB : 0.3482 (-13.32%)

Business Summary

Renovaro Inc. includes RenovaroCube and Renovaro Biosciences. Renovaro Biosciences is an advanced cell-gene-immunotherapy company. Its lead candidate product is a therapeutic vaccine targeting cancers which are difficult to treat including pancreatic and potentially HNC, triple-negative breast cancer,...

See More

Key Turning Points

3rd Resistance Point 0.5237
2nd Resistance Point 0.4858
1st Resistance Point 0.4170
Last Price 0.3482
1st Support Level 0.3103
2nd Support Level 0.2724
3rd Support Level 0.2036

See More

52-Week High 2.3400
Fibonacci 61.8% 1.5689
Fibonacci 50% 1.3307
Fibonacci 38.2% 1.0925
Last Price 0.3482
52-Week Low 0.3214

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro